EMBL Ventures
Investor profile
Deals
4
distinct rounds
Companies
3
backed
Active span
2015–2021
7 yrs
Total round €
€63M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Allecra Therapeutics | Germany | 2 | €37M |
| Topas Therapeutics | Germany | 1 | €18M |
| Luxendo | Germany | 1 | €8.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Allecra Therapeutics | Series B | €22M | 2016-05 |
| Topas Therapeutics | Series B | €18M | 2021-07 |
| Allecra Therapeutics | Series A | €15M | 2015-03 |
| Luxendo | Series A | €8.0M | 2016-12 |